Photon Radiosurgery System

Photon Radiosurgery System

Radiation oncology A system for treating malignant intracranial and possibly other tumors, by delivering high-dose x-rays via a needle-like probe directly to a target
References in periodicals archive ?
Carl Zeiss is the exclusive worldwide distributor (other than Japan) of the Company's PRS Photon Radiosurgery System and the Company's INTRABEAM(TM) system.
The SNN is pleased to welcome Photoelectron, manufacturer of the Photon Radiosurgery System," says Mr.
Bortolo Hospital in Vicenza (Italy) has purchased a Photoelectron Photon Radiosurgery System (PRS).
com), developer of a miniature x-ray system for tumor therapy, announced today that its strategic partner, Carl Zeiss (Oberkochen, Germany), has received an order for its Photon Radiosurgery System (PRS) from the Walton Hospital (Liverpool, UK).
The study will evaluate whether Photoelectron's, Photon Radiosurgery System (PRS) can be used to deliver radiation in the operating room as an alternative to several weeks of radiation therapy using high energy x-ray equipment.
6 /PRNewswire/ -- Photoelectron Corporation (PeC), (Amex: PHX), developer of the Photon Radiosurgery System (PRS), a proprietary x-ray delivery system, today announced receipt of an order for a PRS400 System from Children's Memorial Hospital, Chicago, Illinois.
1 /PRNewswire/ -- Photoelectron Corporation (PeC) (Nasdaq: PECX), developer of the Photon Radiosurgery System (PRS), a proprietary x-ray delivery system for tumor therapy, today announced the launch of two new product combinations based on its miniature x-ray source.
June 29 /PRNewswire/ -- Photoelectron Corporation (PeC) (Nasdaq: PECX), developer of the Photon Radiosurgery System (PRS), a proprietary x-ray delivery system for tumor therapy, announced today receipt of an Investigational Device Exemption (IDE) from the Food and Drug Administration for its applicator system.
June 28 /PRNewswire/ -- Photoelectron Corporation (Nasdaq: PECX), developer of the Photon Radiosurgery System (PRS), a proprietary x-ray delivery system for tumor therapy, announced today the receipt of an order for the PRS400 System from The Cleveland Clinic Foundation.
March 12 /PRNewswire/ -- Photoelectron Corporation (Nasdaq: PECX), developer of the Photon Radiosurgery System (PRS), a proprietary x-ray system for tumor therapy, announced today that that Euan Thomson, Ph.
22 /PRNewswire/ -- Photoelectron Corporation (Nasdaq: PECX), developer of the Photon Radiosurgery System (PRS), a proprietary x-ray system for tumor therapy, announced today management and director appointments at its wholly owned subsidiary, Photoelectron (Europe) Limited, headquartered in London, England.
July 30 /PRNewswire/ -- Photoelectron Corporation (Nasdaq: PECX), developer of the Photon Radiosurgery System (PRS), a proprietary x-ray delivery system for tumor therapy, announced today the commencement of skin tumor trials at Our Lady of Mercy Medical Center, a University Hospital of New York Medical College in New York.